Table 2.

Baseline demographic and efficacy outcome measures, mean ± SE.

	Placebo, n = 85	Kan Jang®, n = 94	Mean difference	p-value
Age, years	34.08 ± 1.52	35.62 ± 1.314	−0.164	0.3814
Males/Females	41/44	47/47	6/3	>0.05
Sore throat	5.471 ± 0.057	5.415 ± 0.055	0.056	0.4030
Runny nose	5.647 ± 0.052	5.564 ± 0.054	0.083	0.3075
Nasal congestion	5.659 ± 0.052	5.553 ± 0.051	0.106	0.2148
Hoarseness	5.612 ± 0.056	5.479 ± 0.058	0.133	0.1626
Cough	5.600 ± 0.058	5.489 ± 0.056	0.111	0.2503
Headache	5.365 ± 0.076	5.340 ± 0.056	0.025	0.5938
Fatigue	5.388 ± 0.075	5.351 ± 0.056	0.037	0.5200
Total mean	5.535 ± 0.047	5.456 ± 0.090	0.079	0.2086

Abbreviations: SE, standard error of the mean. Baseline blood hematology analysis results at the beginning of URTI are shown in Supplement 5.